GRAY SUSANNAH 4
4 · 4D Molecular Therapeutics, Inc. · Filed May 23, 2024
Insider Transaction Report
Form 4
GRAY SUSANNAH
Director
Transactions
- Award
Stock Option (Right To Buy)
2024-05-21+22,500→ 22,500 totalExercise: $25.15Exp: 2034-05-20→ Common Stock (22,500 underlying)
Footnotes (2)
- [F1]Automatically granted pursuant to the terms of the Company's non-employee director compensation program.
- [F2]The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 21, 2025 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 21, 2027. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).